Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP260078.RAoCYTMHXBc-0Vsfr2DhV7AGff66LaxsFDH9HlxOQM-OY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP260078.RAoCYTMHXBc-0Vsfr2DhV7AGff66LaxsFDH9HlxOQM-OY130_assertion type Assertion NP260078.RAoCYTMHXBc-0Vsfr2DhV7AGff66LaxsFDH9HlxOQM-OY130_head.
- NP260078.RAoCYTMHXBc-0Vsfr2DhV7AGff66LaxsFDH9HlxOQM-OY130_assertion description "[Results of these experiments indicate that severity of the articular disease was significantly reduced in the groups of mice treated with CHO/IL-4 or CHO/IL-13 cells encapsulated in HF, compared with control groups receiving CHO/betagal cells encapsulated in HF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP260078.RAoCYTMHXBc-0Vsfr2DhV7AGff66LaxsFDH9HlxOQM-OY130_provenance.
- NP260078.RAoCYTMHXBc-0Vsfr2DhV7AGff66LaxsFDH9HlxOQM-OY130_assertion evidence source_evidence_literature NP260078.RAoCYTMHXBc-0Vsfr2DhV7AGff66LaxsFDH9HlxOQM-OY130_provenance.
- NP260078.RAoCYTMHXBc-0Vsfr2DhV7AGff66LaxsFDH9HlxOQM-OY130_assertion SIO_000772 10444273 NP260078.RAoCYTMHXBc-0Vsfr2DhV7AGff66LaxsFDH9HlxOQM-OY130_provenance.
- NP260078.RAoCYTMHXBc-0Vsfr2DhV7AGff66LaxsFDH9HlxOQM-OY130_assertion wasDerivedFrom befree-2016 NP260078.RAoCYTMHXBc-0Vsfr2DhV7AGff66LaxsFDH9HlxOQM-OY130_provenance.
- NP260078.RAoCYTMHXBc-0Vsfr2DhV7AGff66LaxsFDH9HlxOQM-OY130_assertion wasGeneratedBy ECO_0000203 NP260078.RAoCYTMHXBc-0Vsfr2DhV7AGff66LaxsFDH9HlxOQM-OY130_provenance.